Professional Diversity Network Acquires Additional 20% Stake in RemoteMore USA

Professional Diversity Network, Inc. (NASDAQ:IPDN) ("PDN" or the "Company"), a developer and operator of online and in-person networks that provide access to networking, training, educational and

Professional Diversity Network, Inc. (NASDAQ:IPDN) (“PDN” or the “Company”), a developer and operator of online and in-person networks that provide access to networking, training, educational and employment opportunities for diverse individuals, announced the acquisition of additional 20% of equity interest in RemoteMore USA, Inc. (“RemoteMore”) on March 23, 2023, an online platform specializing in remote-hiring of software developers, increasing PDN’s ownership position in RemoteMore to approximately 66% after the transaction.

Recognizing the unstoppable trend of remote working and the surged demand of a curated workforce pool, PDN purchased approximately 46% of equity interest in RemoteMore back in September 2021. Since that acquisition, RemoteMore has continuously grown its revenue and operations. During the first three quarters of 2022, RemoteMore booked approximately $1,882,000 of gross revenue, six times more than the same period in 2021, increased registered company users from 650 to 1,500, and pre-screened developers from 6,300 to 24,000+ coming from all around the world.

Total
0
Shares
Related Posts
Read More

AstraZeneca, Merck Provided Update on US Regulatory Priority Review of Lynparza in Combination With Abiraterone in Metastatic Castration-resistant Prostate Cancer

AstraZeneca and MSD today announced that the US Food and Drug Administration (FDA) has informed AstraZeneca that it will extend the Prescription Drug User Fee Act (PDUFA) date by three months to provide further time for a full review of the supplementary new drug application (sNDA) for Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone for the treatment of metastati

AZN